Detalhe da pesquisa
1.
Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial.
Lancet
; 395(10233): 1361-1373, 2020 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32334702
2.
Community acceptance of reactive focal mass drug administration and reactive focal vector control using indoor residual spraying, a mixed-methods study in Zambezi region, Namibia.
Malar J
; 20(1): 162, 2021 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33752673
3.
"We were afraid of the lion that has roared next to us"; community response to reactive focal mass drug administration for malaria in Eswatini (formerly Swaziland).
Malar J
; 18(1): 238, 2019 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31307494
4.
Subpatent malaria in a low transmission African setting: a cross-sectional study using rapid diagnostic testing (RDT) and loop-mediated isothermal amplification (LAMP) from Zambezi region, Namibia.
Malar J
; 17(1): 480, 2018 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30567537
5.
Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trial.
BMJ Open
; 12(6): e049050, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35738650
6.
Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial.
EClinicalMedicine
; 44: 101272, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35198913
7.
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.
BMJ Glob Health
; 6(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193475